Is the revised International staging system for myeloma valid in a real world population?

Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management

(2016) S. Vincent Rajkumar   AMERICAN JOURNAL OF HEMATOLOGY

Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma

(2016) Saad Z. Usmani et al.   BLOOD

A single centre retrospective analysis of diagnostic fluorescence in situ hybridisation reveals distinct groups of cytogenetic abnormalities, which affect early survival of new myeloma diagnosis

(2015) I. Walker et al.   Clinical Lymphoma Myeloma & Leukemia

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

(2015) Antonio Palumbo et al.   JOURNAL OF CLINICAL ONCOLOGY

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)

(2011) A. Palumbo et al.   BLOOD

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review

(2009) R Fonseca et al.   LEUKEMIA